ProBDNF as an Indicator of Improvement among Women with Depressive Episodes

Weronika Zwolińska, Maria Skibinska, Agnieszka Słopień, Monika Dmitrzak-Węglarz

Open source

DOI
10.3390/metabo12040358
Published
2022-04-16
Container
Metabolites
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/metabo12040358,
  title = {ProBDNF as an Indicator of Improvement among Women with Depressive Episodes},
  author = {Weronika Zwolińska and Maria Skibinska and Agnieszka Słopień and Monika Dmitrzak-Węglarz},
  year = {2022},
  journal = {Metabolites},
  doi = {10.3390/metabo12040358},
  url = {https://doi.org/10.3390/metabo12040358}
}

RIS

TY  - JOUR
TI  - ProBDNF as an Indicator of Improvement among Women with Depressive Episodes
AU  - Weronika Zwolińska
AU  - Maria Skibinska
AU  - Agnieszka Słopień
AU  - Monika Dmitrzak-Węglarz
PY  - 2022
JO  - Metabolites
DO  - 10.3390/metabo12040358
UR  - https://doi.org/10.3390/metabo12040358
ER  - 

APA

Zwolińska, W., Skibinska, M., Słopień, A., & Dmitrzak-Węglarz, M. (2022). ProBDNF as an Indicator of Improvement among Women with Depressive Episodes. Metabolites. https://doi.org/10.3390/metabo12040358

Source records